โน๏ธ Skipped - page is already crawled
| Filter | Status | Condition | Details |
|---|---|---|---|
| HTTP status | PASS | download_http_code = 200 | HTTP 200 |
| Age cutoff | PASS | download_stamp > now() - 6 MONTH | 0 months ago |
| History drop | PASS | isNull(history_drop_reason) | No drop reason |
| Spam/ban | PASS | fh_dont_index != 1 AND ml_spam_score = 0 | ml_spam_score=0 |
| Canonical | PASS | meta_canonical IS NULL OR = '' OR = src_unparsed | Not set |
| Property | Value |
|---|---|
| URL | https://www.sinovac.com/en-us/contact |
| Last Crawled | 2026-04-12 04:30:37 (4 hours ago) |
| First Indexed | 2025-01-24 11:28:47 (1 year ago) |
| HTTP Status Code | 200 |
| Meta Title | Contact Us-SINOVAC: Supply Vaccines to Eliminate Human Diseases |
| Meta Description | SINOVAC: Supply Vaccines to Eliminate Human Diseases |
| Meta Canonical | null |
| Boilerpipe Text | Add
20 Cecil Street, #06-03 Plus, Singapore 049705
Zip Code
049705
Email
sgkx-gmo@sinovac.com
Add
Flat/Rm 1906, 19/F, Lucky Commercial Building, 103 Des Voeux Road West HK, Sheung Wan, Hong Kong S.A.R., PRC.
Tel
+852-55480884
Fax
+852-39057791
Email
hksales@sinovac.com
Add
No. 540 Mercury Tower, Unit 1144, 11th Floor, Ploenchit Road, Lumpini Sub-district, Pathumwan District, Bangkok Metropolis
Tel
66-2-207-5476
Email
thaimed@sinovac.com
Add
5th Floor Gateway Tower, Gen Roxas Avenue Corner, Gen Aguinaldo Avenue, Araneta Center Cubao, Quezon City, 1109, Philippines
Email
sinovac-philippines@sinovac.com
Add
Anamika Concord, H -583, 11- F, West, Shewrapara, Begum Rokyea Shoroni, Mirpur, Dhaka-1216
Email
info.svabd@sinovac.com
Add
Sampoerna Strategic Square, South Tower, Level 26, Jl. Jend. Sudirman Kav. 45-46, Jakarta 12930, Indonesia
Tel
62-081210535397
Email
elhl8544@sinovac.com
Add
Guacolda 2151 LT-B, Quilicura, Santiago, Chile
Email
info@sinovac.com |
| Markdown | [](https://www.sinovac.com/en-us "SINOVAC: Supply Vaccines to Eliminate Human Diseases")
- [Company](https://www.sinovac.com/en-us/%20%20%20%20javascript:; "Company")
- [SINOVAC at Glance](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/about#met_148)
- [Our History](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/about#met_438)
- [Social Responsibilities](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/about#met_433)
- [Innovation](https://www.sinovac.com/en-us/%20%20%20%20javascript:; "Innovation")
- [Platform](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/research#met_167)
- [Pipeline](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/research#met_168)
- [Scientific Achievements](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/research#met_169)
- [Partners](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/research#met_170)
- [โ Research Institute](https://www.sinovac.com/en-us/research/partners/Research_Institute)
- [โ Universities](https://www.sinovac.com/en-us/research/partners/Universities)
- [โ Medical Institutions](https://www.sinovac.com/en-us/research/partners/Medical_institutions)
- [โ Companies](https://www.sinovac.com/en-us/research/partners/companies)
- [Products](https://www.sinovac.com/en-us/%20%20%20%20javascript:; "Products")
- [Vaccines](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/products#met_440)
- [International Business](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/products#met_165)
- [Quality Management System](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/products#met_173)
- [Product Consultation](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/products/consultation)
- [Adverse Event Report](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/aefi)
- [News](https://www.sinovac.com/en-us/%20%20%20%20javascript:; "News")
- [Press Releases](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/news#met_154)
- [Updates and Statements](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/news#met_155)
- [Media Asset Library](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/news#met_434)
- [Investors](https://www.sinovac.com/en-us/%20%20%20%20javascript:; "Investors")
- [Corporate Governance](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/Investors/corporate_governance/Board_of_Directors)
- [Financial Reports](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/Investors/financial_reports)
- [SEC Filings](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/Investors/sec_filings)
- [Careers](https://www.sinovac.com/en-us/%20%20%20%20javascript:; "Careers")
- [Our Talent](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/careers/talents)
- [ไธญๆ]("้พๆฅๅ
ณ้ฎ่ฏ") [EN]("้พๆฅๅ
ณ้ฎ่ฏ")
- [Contact Us](https://www.sinovac.com/en-us/contact)
- [Company](https://www.sinovac.com/en-us/%20%20%20%20javascript:;)
- [SINOVAC at Glance](https://www.sinovac.com/en-us/about/at_glance_cn)
- [Our History](https://www.sinovac.com/en-us/about/Our_History)
- [Social Responsibilities](https://www.sinovac.com/en-us/about/Responsibilities)
- [News](https://www.sinovac.com/en-us/%20%20%20%20javascript:;)
- [Press Releases](https://www.sinovac.com/en-us/news/release)
- [Updates and Statements](https://www.sinovac.com/en-us/news/coverage)
- [Media Asset Library](https://www.sinovac.com/en-us/news/Media)
- [โ Logo](https://www.sinovac.com/en-us/download2/class-435)
- [โ Vaccines](https://www.sinovac.com/en-us/download2/class-436)
- [Innovation](https://www.sinovac.com/en-us/%20%20%20%20javascript:;)
- [Platform](https://www.sinovac.com/en-us/research/platform)
- [Pipeline](https://www.sinovac.com/en-us/research/pipeline)
- [Scientific Achievements](https://www.sinovac.com/en-us/research/achievements)
- [Partners](https://www.sinovac.com/en-us/research/partners)
- [โ Research Institute](https://www.sinovac.com/en-us/research/partners/Research_Institute)
- [โ Universities](https://www.sinovac.com/en-us/research/partners/Universities)
- [โ Medical Institutions](https://www.sinovac.com/en-us/research/partners/Medical_institutions)
- [โ Companies](https://www.sinovac.com/en-us/research/partners/companies)
- [Products](https://www.sinovac.com/en-us/%20%20%20%20javascript:;)
- [Vaccines](https://www.sinovac.com/en-us/products/portfolio)
- [International Business](https://www.sinovac.com/en-us/products/international-business)
- [Quality Management System](https://www.sinovac.com/en-us/products/publicity)
- [Product Consultation](https://www.sinovac.com/en-us/products/consultation)
- [Adverse Event Report](https://www.sinovac.com/en-us/aefi)
- [Investors](https://www.sinovac.com/en-us/%20%20%20%20javascript:;)
- [Corporate Governance](https://www.sinovac.com/en-us/Investors/corporate_governance/Board_of_Directors)
- [โ Board of Directors](https://www.sinovac.com/en-us/Investors/corporate_governance/Board_of_Directors)
- [โ Board Committees & Charters](https://www.sinovac.com/en-us/Investors/corporate_governance/Board_Committees_and_Charters)
- [Financial Reports](https://www.sinovac.com/en-us/Investors/financial_reports)
- [โ YEAR 2024](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2023)
- [โ YEAR 2023](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2024)
- [โ YEAR 2021](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2021)
- [โ YEAR 2022](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2022)
- [โ YEAR 2020](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2020)
- [โ YEAR 2019](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2019)
- [โ YEAR 2018](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2018)
- [โ YEAR 2017](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2017)
- [โ YEAR 2016](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2016)
- [โ YEAR 2015](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2015)
- [โ YEAR 2014](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2014)
- [โ YEAR 2013](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2013)
- [โ YEAR 2012](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2012)
- [โ YEAR 2011](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2011)
- [โ YEAR 2010](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2010)
- [โ YEAR 2009](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2009)
- [โ YEAR 2008](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2008)
- [โ YEAR 2007](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2007)
- [โ YEAR 2006](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2006)
- [โ YEAR 2005](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2005)
- [โ YEAR 2004](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2004)
- [โ YEAR 2003](https://www.sinovac.com/en-us/Investors/financial_reports/financial_reports_2003)
- [SEC Filings](https://www.sinovac.com/en-us/Investors/sec_filings)
- [โ YEAR 2025](https://www.sinovac.com/en-us/Investors/sec_filings/sec_filings2025)
- [โ YEAR 2024](https://www.sinovac.com/en-us/Investors/sec_filings/SEC)
- [โ YEAR 2023](https://www.sinovac.com/en-us/Investors/sec_filings/SEC%20Filings_2023)
- [โ YEAR 2022](https://www.sinovac.com/en-us/Investors/sec_filings/SEC%20Filings_2022)
- [โ YEAR 2021](https://www.sinovac.com/en-us/Investors/sec_filings/SEC%20Filings_2021)
- [โ YEAR 2020](https://www.sinovac.com/en-us/Investors/sec_filings/SEC%20Filings_2020)
- [โ YEAR 2019](https://www.sinovac.com/en-us/Investors/sec_filings/SEC%20Filings_2019)
- [โ YEAR 2018](https://www.sinovac.com/en-us/Investors/sec_filings/SEC%20Filings_2018)
- [โ YEAR 2017](https://www.sinovac.com/en-us/Investors/sec_filings/SEC%20Filings_2017)
- [โ YEAR 2016](https://www.sinovac.com/en-us/Investors/sec_filings/SEC%20Filings_2016)
- [โ YEAR 2015](https://www.sinovac.com/en-us/Investors/sec_filings/SEC%20Filings_2015)
- [โ YEAR 2014](https://www.sinovac.com/en-us/Investors/sec_filings/SEC%20Filings_2014)
- [โ YEAR 2013](https://www.sinovac.com/en-us/Investors/sec_filings/SEC%20Filings_2013)
- [โ YEAR 2012](https://www.sinovac.com/en-us/Investors/sec_filings/SEC%20Filings_2012)
- [โ YEAR 2011](https://www.sinovac.com/en-us/Investors/sec_filings/SEC%20Filings_2011)
- [โ YEAR 2010](https://www.sinovac.com/en-us/Investors/sec_filings/SEC%20Filings_2010)
- [โ YEAR 2009](https://www.sinovac.com/en-us/Investors/sec_filings/SEC%20Filings_2009)
- [Careers](https://www.sinovac.com/en-us/%20%20%20%20javascript:;)
- [Our Talent](https://www.sinovac.com/en-us/careers/talents)
- [Contact Us](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/contact)
- [่็ณปๆไปฌ](https://www.sinovac.com/zh-cn/contact)
ๅฝๅๅฐ็น๏ผ
[ EN](https://www.sinovac.com/en-us "EN")
้ๆฉๅฐ็น๏ผ
- [ ไธญๆ]("ไธญๆ")
- [ EN]("EN")
[](https://www.sinovac.com/en-us "SINOVAC: Supply Vaccines to Eliminate Human Diseases")
- [Home](https://www.sinovac.com/en-us)
- [Company](https://www.sinovac.com/en-us/%20%20%20%20javascript:; "Company")
- [SINOVAC at Glance](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/about#met_148 "SINOVAC at Glance")
- [Our History](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/about#met_438 "Our History")
- [Social Responsibilities](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/about#met_433 "Social Responsibilities")
- [News](https://www.sinovac.com/en-us/%20%20%20%20javascript:; "News")
- [Press Releases](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/news#met_154 "Press Releases")
- [Updates and Statements](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/news#met_155 "Updates and Statements")
- [Media Asset Library](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/news#met_434 "Media Asset Library")
- [Innovation](https://www.sinovac.com/en-us/%20%20%20%20javascript:; "Innovation")
- [Platform](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/research#met_167 "Platform")
- [Pipeline](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/research#met_168 "Pipeline")
- [Scientific Achievements](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/research#met_169 "Scientific Achievements")
- [Partners](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/research#met_170 "Partners")
- [Products](https://www.sinovac.com/en-us/%20%20%20%20javascript:; "Products")
- [Vaccines](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/products#met_440 "Vaccines")
- [International Business](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/products#met_165 "International Business")
- [Quality Management System](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/products#met_173 "Quality Management System")
- [Product Consultation](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/products/consultation "Product Consultation")
- [Adverse Event Report](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/aefi "Adverse Event Report")
- [Investors](https://www.sinovac.com/en-us/%20%20%20%20javascript:; "Investors")
- [Corporate Governance](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/Investors/corporate_governance/Board_of_Directors "Corporate Governance")
- [Financial Reports](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/Investors/financial_reports "Financial Reports")
- [SEC Filings](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/Investors/sec_filings "SEC Filings")
- [Careers](https://www.sinovac.com/en-us/%20%20%20%20javascript:; "Careers")
- [Our Talent](https://www.sinovac.com/en-us/%20%20%20%20https://www.sinovac.com/en-us/careers/talents "Our Talent")
- [Contact Us](https://www.sinovac.com/en-us/contact)
- [ไธญๆ]("ไธญๆ")
- [EN]("EN")
### Contact Us
***
Sinovac Biotech Ltd.
Add๏ผNo.39, SHANGDI West Road. Haidian District, Beijing, 100085, P.R.China
- Tel
\+86-10-8279-9800
- Fax
\+86-10-6296-6910
- Media Relations
Email: pr@sinovac.com
- Investor Relations
Helen Yang
Tel: +86-10-8279-9720
Email: ir@sinovac.com
### Contact Us
***
Sinovac Biotech Ltd.
Add๏ผNo.39, SHANGDI West Road. Haidian District, Beijing, 100085, P.R.China
- Tel
\+86-10-8289-0088
\+86-10-8279-9740
- Fax
\+86-10-6296-6910
- Media Relations
Email: pr@sinovac.com
- Investor Relations
Helen Yang
Tel: +86-10-8279-9720
Email: ir@sinovac.com
## International Sales
#### Singapore
#### Hong Kong, China
#### Thailand
#### Philippines
#### Bangladesh
#### Indonesia
#### Chile
- Add
20 Cecil Street, \#06-03 Plus, Singapore 049705
- Zip Code
049705
- Email
sgkx-gmo@sinovac.com
- Add
Flat/Rm 1906, 19/F, Lucky Commercial Building, 103 Des Voeux Road West HK, Sheung Wan, Hong Kong S.A.R., PRC.
- Tel
\+852-55480884
- Fax
\+852-39057791
- Email
hksales@sinovac.com
- Add
No. 540 Mercury Tower, Unit 1144, 11th Floor, Ploenchit Road, Lumpini Sub-district, Pathumwan District, Bangkok Metropolis
- Tel
66-2-207-5476
- Email
thaimed@sinovac.com
- Add
5th Floor Gateway Tower, Gen Roxas Avenue Corner, Gen Aguinaldo Avenue, Araneta Center Cubao, Quezon City, 1109, Philippines
- Email
sinovac-philippines@sinovac.com
- Add
Anamika Concord, H -583, 11- F, West, Shewrapara, Begum Rokyea Shoroni, Mirpur, Dhaka-1216
- Email
info.svabd@sinovac.com
- Add
Sampoerna Strategic Square, South Tower, Level 26, Jl. Jend. Sudirman Kav. 45-46, Jakarta 12930, Indonesia
- Tel
62-081210535397
- Email
elhl8544@sinovac.com
- Add
Guacolda 2151 LT-B, Quilicura, Santiago, Chile
- Email
info@sinovac.com

- Follow Us
- [](https://www.sinovac.com/en-us/%20%20%20%20https://www.instagram.com/sinovacbiotech/)
- [](https://www.sinovac.com/en-us/%20%20%20%20https://twitter.com/Sinovac)
- [](https://www.sinovac.com/en-us/%20%20%20%20https://twitter.com/Sinovac)
- [](https://www.sinovac.com/en-us/%20%20%20%20https://www.facebook.com/SinovacBiotechSVA)
- [](https://www.sinovac.com/en-us/%20%20%20%20https://www.youtube.com/@SinovacBiotech)
- [](https://www.sinovac.com/en-us/%20%20%20%20https://www.linkedin.com/company/sinovac-biotech-ltd./)
![]()
ยฉ SINOVAC All rights reserved |
| Readable Markdown | - Add
20 Cecil Street, \#06-03 Plus, Singapore 049705
- Zip Code
049705
- Email
sgkx-gmo@sinovac.com
- Add
Flat/Rm 1906, 19/F, Lucky Commercial Building, 103 Des Voeux Road West HK, Sheung Wan, Hong Kong S.A.R., PRC.
- Tel
\+852-55480884
- Fax
\+852-39057791
- Email
hksales@sinovac.com
- Add
No. 540 Mercury Tower, Unit 1144, 11th Floor, Ploenchit Road, Lumpini Sub-district, Pathumwan District, Bangkok Metropolis
- Tel
66-2-207-5476
- Email
thaimed@sinovac.com
- Add
5th Floor Gateway Tower, Gen Roxas Avenue Corner, Gen Aguinaldo Avenue, Araneta Center Cubao, Quezon City, 1109, Philippines
- Email
sinovac-philippines@sinovac.com
- Add
Anamika Concord, H -583, 11- F, West, Shewrapara, Begum Rokyea Shoroni, Mirpur, Dhaka-1216
- Email
info.svabd@sinovac.com
- Add
Sampoerna Strategic Square, South Tower, Level 26, Jl. Jend. Sudirman Kav. 45-46, Jakarta 12930, Indonesia
- Tel
62-081210535397
- Email
elhl8544@sinovac.com
- Add
Guacolda 2151 LT-B, Quilicura, Santiago, Chile
- Email
info@sinovac.com |
| Shard | 74 (laksa) |
| Root Hash | 13504451120479472074 |
| Unparsed URL | com,sinovac!www,/en-us/contact s443 |